Mortality Risk in a Nationwide Cohort of Individuals with Tic Disorders and with Tourette Syndrome
Overview
Affiliations
Background: Few studies have investigated mortality risk in individuals with tic disorders.
Methods: We thus measured the risk of premature death in individuals with tic disorders and with Tourette syndrome in a prospective cohort study with 80 million person-years of follow-up. We estimated mortality rate ratios and adjusted for calendar year, age, sex, urbanicity, maternal and paternal age, and psychiatric disorders to compare individuals with and without tic disorders.
Results: The risk of premature death was higher among individuals with tic disorders (mortality rate ratio, 2.02; 95% CI, 1.49-2.66) and with Tourette syndrome (mortality rate ratio, 1.63; 95% CI, 1.11-2.28) compared with controls. After the exclusion of individuals with comorbid attention-deficit/hyperactivity disorder, obsessive-compulsive disorder, and substance abuse, tic disorder remained associated with increased mortality risk (mortality rate ratio, 2.30; 95% CI, 1.57-3.23), as did also Tourette Syndrome (mortality rate ratio, 1.81; 95% CI, 1.11-2.75).
Conclusions: These results are of clinical significance for clinicians and advocacy organizations. Several factors may contribute to this increased risk of premature death, and more research mapping out these factors is needed. © 2017 International Parkinson and Movement Disorder Society.
All-Cause and Cause-Specific Mortality in Tourette Syndrome and Chronic Tic Disorder.
Fernandez de la Cruz L, Isomura K, Kuja-Halkola R, Lichtenstein P, Larsson H, Chang Z Mov Disord. 2024; 40(2):335-344.
PMID: 39679818 PMC: 11832810. DOI: 10.1002/mds.30084.
Prevalence of Tourette syndrome among children and adolescents in the United States, 2016-2022.
Xiong Y, OBrien M, Yang W, Zang X, Bao W, Xu G BMC Public Health. 2024; 24(1):2699.
PMID: 39363167 PMC: 11451533. DOI: 10.1186/s12889-024-20216-2.
Deep brain stimulation for Tourette's syndrome.
Wang S, Zhang Y, Wang M, Meng F, Liu Y, Zhang J Cochrane Database Syst Rev. 2024; 8:CD015924.
PMID: 39136257 PMC: 11320656. DOI: 10.1002/14651858.CD015924.
Isaacs D, Bonnet K, Eckland M, Markowitz K, Pena M, Schlundt D Neuropsychiatr Dis Treat. 2024; 20:257-269.
PMID: 38351925 PMC: 10863457. DOI: 10.2147/NDT.S442131.
Yu J, Yao X, Zhang X, Hao J Front Neurosci. 2023; 17:1201294.
PMID: 37841690 PMC: 10570423. DOI: 10.3389/fnins.2023.1201294.